JP2006507295A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006507295A5 JP2006507295A5 JP2004549541A JP2004549541A JP2006507295A5 JP 2006507295 A5 JP2006507295 A5 JP 2006507295A5 JP 2004549541 A JP2004549541 A JP 2004549541A JP 2004549541 A JP2004549541 A JP 2004549541A JP 2006507295 A5 JP2006507295 A5 JP 2006507295A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- treatment
- influenza virus
- virus
- suberatororu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- 208000036142 Viral infection Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 206010022000 influenza Diseases 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000562A ITRM20020562A1 (it) | 2002-11-06 | 2002-11-06 | Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza. |
| PCT/IT2003/000626 WO2004041260A1 (en) | 2002-11-06 | 2003-10-14 | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006507295A JP2006507295A (ja) | 2006-03-02 |
| JP2006507295A5 true JP2006507295A5 (cg-RX-API-DMAC7.html) | 2006-11-24 |
| JP4589118B2 JP4589118B2 (ja) | 2010-12-01 |
Family
ID=32310188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004549541A Expired - Lifetime JP4589118B2 (ja) | 2002-11-06 | 2003-10-14 | インフルエンザウイルス感染の治療に有用な医薬の調製のためのリスベラトロールの使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US8431617B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1567137B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4589118B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101060331B1 (cg-RX-API-DMAC7.html) |
| AR (1) | AR041891A1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE381929T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003279551A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2504872C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1107302T1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60318327T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1567137T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2295660T3 (cg-RX-API-DMAC7.html) |
| IT (1) | ITRM20020562A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05004628A (cg-RX-API-DMAC7.html) |
| PL (1) | PL217628B1 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1567137E (cg-RX-API-DMAC7.html) |
| TW (1) | TWI337863B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004041260A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080260690A1 (en) * | 2005-11-18 | 2008-10-23 | Ares Trading S.A. | Interferon in Influenza |
| WO2009136979A2 (en) * | 2008-03-06 | 2009-11-12 | Mount Sinai School Of Medicine Of New York University | Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof |
| EP2349305A4 (en) * | 2008-11-04 | 2012-08-22 | Metaproteomics Llc | PHYTOCHEMICAL COMPOSITIONS AND METHOD FOR AMP-KINASE ACTIVATION |
| AU2009344851A1 (en) * | 2008-12-19 | 2011-06-23 | The Regents Of The University Of California | Use of epidermal growth factor inhibitors in the treatment of viral infection |
| KR100950445B1 (ko) | 2009-10-26 | 2010-04-02 | 주식회사 중앙백신연구소 | 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제 |
| WO2011150413A1 (en) | 2010-05-28 | 2011-12-01 | Mount Sinai School Of Medicine | Antiviral compounds and uses thereof |
| CA2850597A1 (en) * | 2011-09-30 | 2013-04-04 | Vanderbilt University | Antiviral therapies with phospholipase d inhibitors |
| PL2952180T3 (pl) | 2014-06-04 | 2017-05-31 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | STAŁE FORMULACJE ZAWIERAJĄCE RESWERATROL I WIELONIENASYCONE KWASY TŁUSZCZOWE OMEGA-3 (n-3 PUFA) |
| ES2666836T3 (es) | 2014-06-04 | 2018-05-08 | Alfasigma S.P.A. | Formulaciones homogéneas que comprenden ácidos grasos poliinsaturados omega-3 (n-3 PUFA) y resveratrol para administración oral |
| EP3120842A1 (en) * | 2015-07-20 | 2017-01-25 | Opterion Health AG | Peritoneal therapeutic fluid |
| KR20170039456A (ko) | 2015-10-01 | 2017-04-11 | 동아대학교 산학협력단 | 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물 |
| JP2018024592A (ja) * | 2016-08-09 | 2018-02-15 | 株式会社ブレインヘルス | 抗生物質含有組成物 |
| CN108893558B (zh) * | 2018-05-24 | 2022-04-05 | 江苏海宏制药有限公司 | 一种桑木液原液抗病毒实验方法以及装置 |
| EP4132277B1 (en) | 2020-04-05 | 2025-11-26 | Mong, Michael | Systems and methods for treating coronavirus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2778337B1 (fr) * | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | Antagonistes des ligands du recepteur des arylhydrocarbures |
| PE20010540A1 (es) | 1999-07-30 | 2001-05-15 | Procter & Gamble | Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza |
| CA2380924C (en) | 1999-08-13 | 2008-02-19 | University Of Maryland Biotechnology Institute | Compositions for treating viral infections, and methods therefor |
-
2002
- 2002-11-06 IT IT000562A patent/ITRM20020562A1/it unknown
-
2003
- 2003-10-14 DE DE60318327T patent/DE60318327T2/de not_active Expired - Lifetime
- 2003-10-14 PT PT03772659T patent/PT1567137E/pt unknown
- 2003-10-14 KR KR1020057007230A patent/KR101060331B1/ko not_active Expired - Lifetime
- 2003-10-14 MX MXPA05004628A patent/MXPA05004628A/es active IP Right Grant
- 2003-10-14 PL PL377557A patent/PL217628B1/pl unknown
- 2003-10-14 AT AT03772659T patent/ATE381929T1/de active
- 2003-10-14 DK DK03772659T patent/DK1567137T3/da active
- 2003-10-14 JP JP2004549541A patent/JP4589118B2/ja not_active Expired - Lifetime
- 2003-10-14 US US10/533,942 patent/US8431617B2/en not_active Expired - Fee Related
- 2003-10-14 CA CA2504872A patent/CA2504872C/en not_active Expired - Lifetime
- 2003-10-14 EP EP03772659A patent/EP1567137B1/en not_active Expired - Lifetime
- 2003-10-14 AU AU2003279551A patent/AU2003279551A1/en not_active Abandoned
- 2003-10-14 WO PCT/IT2003/000626 patent/WO2004041260A1/en not_active Ceased
- 2003-10-14 ES ES03772659T patent/ES2295660T3/es not_active Expired - Lifetime
- 2003-10-27 TW TW092129780A patent/TWI337863B/zh not_active IP Right Cessation
- 2003-11-05 AR ARP030104047A patent/AR041891A1/es unknown
-
2008
- 2008-03-12 CY CY20081100281T patent/CY1107302T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006507295A5 (cg-RX-API-DMAC7.html) | ||
| JP2009535352A5 (cg-RX-API-DMAC7.html) | ||
| WO2004071426A3 (en) | Compounds for the treatment of viral infection | |
| SV2005001920A (es) | " compuestos nucleosidos para el tratamiento de infecciones virales " | |
| WO2007041487A3 (en) | Viral peptides and their use to inhibit viral infections against viruses of the flaviridae family | |
| IL215891A (en) | Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections | |
| IL207468A (en) | HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections | |
| WO2003051306A3 (en) | N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections | |
| GEP20104960B (en) | USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN | |
| JP2009526751A5 (cg-RX-API-DMAC7.html) | ||
| DE60215157D1 (de) | Verwendungen von antiviralen nucleosid-derivaten zur herstellung eines medikaments zur behandlung von hepatitis c infektionen | |
| WO2005020884A3 (en) | Nucleosides for treatment of infection by corona viruses, toga viruses and picorna viruses | |
| ATE269321T1 (de) | Arzneimittel gegen virale erkrankungen | |
| CA2504872A1 (en) | Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections | |
| JP2022132411A5 (cg-RX-API-DMAC7.html) | ||
| MY144492A (en) | Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types | |
| IL164973A (en) | N-hydroxy formamide compounds, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating bacterial infections | |
| JP2006514949A5 (cg-RX-API-DMAC7.html) | ||
| WO2006044968A3 (en) | Combination therapy for treating viral infections | |
| BRPI0407140A (pt) | Droga terapêutica para vìrus | |
| CL2004002030A1 (es) | Uso de interferon y ribavirina porque sirve para preparar un medicamento para tratar infecciones virales; composicion farmaceutica que comprende interferon, ribavirina y opcionalmente antioxidante; kit y su uso para preparar un medicamento para trata | |
| WO2004033479A3 (en) | Retroyclins: antiviral and antimicrobial peptides | |
| CA2457982A1 (en) | Use of nefiracetam for treating neurodegeneration | |
| NZ599039A (en) | Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry | |
| DE602004025103D1 (de) | Heilkräuterzusammensetzung zur Behandlung von AIDS |